Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 11.25 -1.14% -0.13
INSY closed down 1.14 percent on Friday, April 28, 2017, on 80 percent of normal volume.

Earnings due: May 9

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical INSY trend table...

Date Alert Name Type % Chg
Apr 28 Upper Bollinger Band Walk Other 0.00%
Apr 26 Crossed Above 50 DMA Bullish 0.36%
Apr 26 Expansion Pivot Buy Setup Bullish Swing Setup 0.36%
Apr 20 Narrow Range Bar Range Contraction 7.97%
Apr 19 NR7 Range Contraction 7.86%
Apr 19 NR7-2 Range Contraction 7.86%
Apr 19 Narrow Range Bar Range Contraction 7.86%
Apr 18 NR7 Range Contraction 7.86%
Apr 18 Narrow Range Bar Range Contraction 7.86%
Apr 18 Hammer Candlestick Bullish 7.86%

Older signals for INSY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company’s cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.96
52 Week Low 8.7
Average Volume 880,158
200-Day Moving Average 12.1467
50-Day Moving Average 11.0116
20-Day Moving Average 10.662
10-Day Moving Average 10.677
Average True Range 0.5408
ADX 15.69
+DI 29.72
-DI: 14.66
Chandelier Exit (Long, 3 ATRs) 10.2176
Chandelier Exit (Short, 3 ATRs) 11.4824
Upper Bollinger Band 11.5142
Lower Bollinger Band 9.8098
Percent B (%b) 0.84
Bandwidth 0.159857